Cargando…
An Antiphospholipid Antibody Profile as a Biomarker for Thrombophilia in Systemic Lupus Erythematosus
Despite recent advances in treatment and significant improvements in prognosis, thrombosis remains the major cause of death in systemic lupus erythematosus (SLE). Antiphospholipid antibodies (aPL) are the main triggers of thrombosis in patients with SLE, with a frequency of approximately 30–40%. Lup...
Autores principales: | Hisada, Ryo, Atsumi, Tatsuya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10135455/ https://www.ncbi.nlm.nih.gov/pubmed/37189365 http://dx.doi.org/10.3390/biom13040617 |
Ejemplares similares
-
IgA Antiphospholipid Antibodies in Antiphospholipid Syndrome and Systemic Lupus Erythematosus
por: Reshetnyak, Tatiana, et al.
Publicado: (2022) -
Insights into the Procoagulant Profile of Patients with Systemic Lupus Erythematosus without Antiphospholipid Antibodies
por: Monzón Manzano, Elena, et al.
Publicado: (2020) -
Opposite Profiles of Complement in Antiphospholipid Syndrome (APS) and Systemic Lupus Erythematosus (SLE) Among Patients With Antiphospholipid Antibodies (aPL)
por: Savelli, Stephanie L., et al.
Publicado: (2019) -
Association of Antiphospholipid Antibodies with Clinical Manifestations in Children with Systemic Lupus Erythematosus
por: Petrovic, Gordana, et al.
Publicado: (2023) -
Editorial: Systemic Lupus Erythematosus and Antiphospholipid Syndrome
por: Meroni, Pier Luigi, et al.
Publicado: (2019)